Assorted News from the Last Week: The U.S. Food and Drug Administration (FDA) approved FoundationOne®CDx as a companion diagnostic for Supporting Organization Member Day One
Assorted News from the Last Week: Pope Francis tells pediatric cancer patients they are ‘witnesses of hope.’ Unraveling the relationship between stress exposure and childhood
Assorted News from the Last Week: GLO-BNHL opens first sites of a multi-country platform trial that will offer multiple new treatments and a better chance
Assorted News from the Last Week: Spending package extends medicare telehealth flexibilities for three months and Gabriella Miller Kids First 2.0 reauthorization passes in standalone
Assorted News from the Last Week: Special Advocacy Call to Action: CAC2 Supporting Organization LLS is spearheading an effort and inviting all in the community
There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years
Assorted News from the Last Week: The simple act of asking young patients about their symptoms regularly during cancer treatment can help them get more
During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of
Assorted News from the Last Week: CAC2 Individual Member Jennifer Flowers writes compellingly about “When the National Drug Shortage Becomes Personal” for her. Published in
Assorted News from the Last Week: Last week the FDA reported that it is investigating reports of blood cancers — including life-threatening cases of myelodysplastic
